African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12487

Full Length Research Paper

Impact of nucleotide polymorphisms at drug resistance sites on genetic barrier in human immunodeficiency virus type 1 subtype C resistance evolution

Benson Chuks Iweriebor1*, Tracy Masebe1, Julius Nwobegahay1, Jeffrey M. Mphahlele2 and Pascal Obong Bessong1
1AIDS Virus Research Laboratory, Department of Microbiology, University of Venda, South Africa. 2HIV and Hepatitis Research Unit, Department of Virology, University of Limpopo, Medunsa Campus, South Africa.
Email: [email protected]

  •  Accepted: 05 August 2011
  •  Published: 30 November 2012

Abstract

Genetic diversity is the hallmark of human immunodeficiency virus (HIV), the causative agent of acquired immune deficiency syndrome (AIDS). This diversity has resulted in a spectrum of different subtypes within the group M viruses that is responsible for the AIDS pandemic. Nucleotide substitutions and polymorphisms at codons known to confer drug resistance in subtype B viruses were compared with similar substitutions in subtype C viruses. Genetic barrier was determined on viruses isolated from drug naive patients infected with subtype C viruses. We found a reduced genetic barrier in subtype C viruses at codon V106M (GTA to ATG) and an increased barrier at codon L210W (TTA/CTG/CTA to TGG) when compared to subtype B consensus. The highest genetic barrier in subtype C viruses is found at codon Q151M where two transversions or each one of transition and transversion are needed for the resistance evolution.

 

Key words: Human immunodeficiency virus (HIV), drug resistance, genetic barrier, non-B subtypes.